Mackay Shields LLC Supernus Pharmaceuticals, Inc. Transaction History

Mackay Shields LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$26.72 - $33.19 $1.05 Million - $1.3 Million	-39,200 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$24.15 - $31.45 $603,750 - $786,250	-25,000 Reduced 38.94%	39,200 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$17.7 - $25.81 $424,800 - $619,440	24,000 Added 59.7%	64,200 $1.62 Million
Q3 2020 Nov 04, 2020	BUY	$20.2 - $25.05 $193,920 - $240,480	9,600 Added 31.37%	40,200 $838,000
Q2 2020 Jul 31, 2020	SELL	$17.09 - $24.89 $39,307 - $57,247	-2,300 Reduced 6.99%	30,600 $727,000
Q4 2019 Feb 11, 2020	BUY	$19.93 - $29.13 $655,697 - $958,377	32,900 New	32,900 $781,000
Q2 2019 Aug 13, 2019	SELL	$29.96 - $38.87 $295,195 - $382,986	-9,853 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$32.77 - $41.99 $373 Million - $478 Million	-11,395,000 Reduced 99.91%	9,853 $346,000
Q1 2019 May 13, 2019	BUY	$32.77 - $41.99 $373 Million - $478 Million	11,395,000 Added 115650.06%	11,404,853 $11.4 Million
Q4 2018 Feb 14, 2019	BUY	$30.84 - $49.51 $303,866 - $487,822	9,853 New	9,853 $328,000
Q2 2018 Aug 06, 2018	SELL	$44.1 - $59.85 $3.99 Million - $5.42 Million	-90,500 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$37.15 - $46.9 $3.36 Million - $4.24 Million	90,500 New	90,500 $4.15 Million

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.